Recruiting Fabry Disease Studies in St Louis
About Fabry Disease Clinical Trials in St Louis
Fabry disease is a rare genetic disorder caused by deficiency of the enzyme alpha-galactosidase A, leading to accumulation of a fatty substance in cells. It can affect the heart, kidneys, and nervous system. Treatment includes enzyme replacement therapy and chaperone therapy.
There are currently 1 fabry disease clinical trials recruiting participants in St Louis, MO. These studies are seeking a combined 450 participants. Research is being sponsored by Amicus Therapeutics. Clinical trial participation is free and participants receive study-related medical care at no cost.
Fabry Disease Clinical Trials in St Louis — FAQ
Are there fabry disease clinical trials in St Louis?
Yes, there are 1 fabry disease clinical trials currently recruiting in St Louis, MO. Browse the studies on this page to find one that fits.
How do I join a clinical trial in St Louis?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the St Louis research site will contact you about next steps.
Are clinical trials in St Louis free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many St Louis studies also compensate for your time and travel.
What fabry disease treatments are being tested?
The 1 active trials in St Louis are testing new therapies including novel drugs, biologics, and treatment approaches for fabry disease.
Data updated October 12, 2026 from ClinicalTrials.gov